Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone and dye-assisted intraocular surgery (adjuvant visibility study)
jRCTs041180066Completed
- Start
- Apr 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of triamcinolone acetonide, brilliant blue G, indocyanine green and fluorescein in cataract and vitreoretinal disease (VRD). Primary endpoint: visual acuity. Started Apr 2019; status: completed.
02
Drugs
triamcinolone acetonidebrilliant blue Gindocyanine greenfluorescein
03
Conditions
cataractvitreoretinal disease (VRD)
Beyond the preview
Go deeper on jRCTs041180066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041180066.